Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata causes sudden hair loss, has genetic links, and can be managed but not cured.

COVID-19 vaccination does not significantly increase the risk of developing alopecia areata.

More effective treatments are needed for severe alopecia areata.

A man developed myasthenia gravis after alopecia areata, and treatment improved his symptoms and stopped hair loss.

People with non-scarring hair loss often have lower vitamin D levels than those without hair loss.

A protein from fat-derived stem cells, DKK1, is linked to hair loss and blocking it may help treat alopecia areata.

Alopecia areata patients have higher levels of certain immune receptors, suggesting new treatment possibilities.

Trichoscopy is essential for diagnosing and managing alopecia areata in children.

Reducing the dose of Baricitinib to 2mg still helped over half of the patients with severe scalp alopecia maintain their hair regrowth after two years.

Tiny particles from umbilical cord stem cells may help hair grow back in a type of hair loss.

Blocking TYK2 might be a new way to treat hair loss from alopecia areata.

The document concludes that a new questionnaire to assess mental health in alopecia patients shows low rates of seeking mental health services and support groups.

JAK inhibitors partially restore scalp bacteria balance in alopecia areata patients.

γδTregs can protect hair follicles from alopecia areata and may help regrow hair.

Pulse corticosteroids help regrow hair in alopecia areata but have side effects, especially betamethasone.

Baricitinib treatment helped reduce hair loss symptoms in mice by decreasing inflammation-related immune cells.

PPAR-γ may be a key target for treating alopecia areata and other skin conditions.

Combining medication for dyslipidemia and insulin resistance with basic therapy improves outcomes for alopecia areata with metabolic syndrome.

Alopecia areata costs individuals about 3% of their income, with women, Asians, those with lower income, and more severe symptoms spending more.

Oxidative stress is linked to mild patchy alopecia areata.

New treatment for hair loss using special microneedles shows promise in reducing inflammation and promoting hair growth.

New treatments targeting the JAK signaling pathway, especially JAK inhibitors, show promise for alopecia areata.

People with common hair loss conditions may have a higher risk of heart disease and related health issues.

Baricitinib is a promising treatment for alopecia areata.

Tofacitinib is a safe and effective treatment for hair loss in children with Alopecia Areata.

Baricitinib effectively regrows hair in most people with severe alopecia, especially those with patchy hair loss, but hair may fall out again if treatment stops.

Hair regrowth from severe alopecia areata treatment with baricitinib can vary, with faster results in those with shorter hair loss duration.

Ritlecitinib effectively improves hair growth in alopecia areata patients, regardless of hair loss pattern.

The study suggests that analyzing DNA can help treat hair loss, but more research is needed.

Alopecia areata may be linked to hearing problems, so patients should monitor their hearing.